Frank Bradford
2.2K posts



Today, the FDA announced that on May 16, 2024, the FDA’s Vaccines and Related Biological Products Advisory Committee will meet to publicly discuss and make recommendations on the selection of strain(s) to be included in the 2024-2025 formula for COVID-19 vaccines. fda.gov/advisory-commi… The FDA anticipates that changes to the vaccine composition may need to be made based on the currently circulating strains of the virus that causes COVID-19. As the agency has previously stated, barring any new major changes to circulating virus, the FDA expects that the composition of COVID-19 vaccines may need to be updated annually, as is done for the seasonal influenza vaccine. Following any potential recommendations to update the 2024-2025 formula, the FDA anticipates taking the appropriate regulatory actions on the updated COVID-19 vaccines so that manufacturers will be able to make them available by September.





Florida reported more than 10,000 new COVID cases this week, up 60% from last week






